Account wins

Share this article:

Allergan awarded Pacific Communications the DTC assignment for its severe axillary hyperhidrosis (severe underarm sweating) indication on Botox following a competitive pitch.The campaign, featuring print ads in women's magazines as well as patient brochures and in-office materials, will target young professional women, emphasizing expanded wardrobe possibilities when underarm sweating is brought under control. Pacific Communications already handles professional advertising for the brand, but DTC has traditionally been tasked to big consumer shops. The Costa Mesa, CA, agency first launched Botox as Allergan's in-house shop but was spun off in 1993 and lost the business before regaining professional advertising for the brand in 2004.FDA approved the hyperhidrosis indication in July 2004 on the strength of two clinical trials involving more than 600 adults. One study showed that 91% of adults receiving Botox halved their sweating, while only a third of those receiving a placebo showed similar improvement. Botox (Botulinum Toxin Type A) was first approved in 1989 to treat two eye muscle disorders but has since expanded into numerous other medical and cosmetic indications.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

DOJ closes Brilinta investigation

AstraZeneca announced the end of the investigation Tuesday.

Doctors back unique biosimilar names

A host of doctors has asked FDA Commissioner Margaret Hamburg to back a naming convention that would require biologics and biosimilars to have different names.

Roche has no rights to Sovaldi, panel rules

Despite a collaboration with original Sovaldi owner Pharmasset in 2004, a panel ruled Roche has no rights to HCV treatment Sovaldi.